Trihexyphenidyl Hydrochloride Oral Solution Recalled for Unverified Stability
All lots of Trihexyphenidyl Hydrochloride Oral Solution (2mg/5mL) distributed nationwide have been recalled. The manufacturer went out of business and could not complete stability studies needed to verify the drug's safety over time.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall, indicating potential for harm. However, no illnesses or injuries have been reported. The hazard is theoretical—the inability to verify drug stability due to incomplete manufacturing studies—not a confirmed product defect or contamination.
Plain-English summary
The FDA has issued a Class II recall for all lots of Trihexyphenidyl Hydrochloride Oral Solution, USP, 2 mg/5 mL, distributed by VersaPharm, Inc. (an Akorn Company) nationwide and in Puerto Rico. The recall is due to manufacturing practice deviations.
The manufacturer, Akorn, Inc., went out of business and was unable to continue stability studies required to demonstrate that the medication remains safe and effective over its shelf life. Without completed stability data, the agency cannot verify that the drug maintains its safety and efficacy throughout its intended use period.
If you have this medication, contact your healthcare provider or pharmacist for guidance on whether to continue using it or switch to an alternative. Do not stop taking necessary medications without medical advice. Return any unused product to your pharmacy for proper disposal.
The recalled product
- Product
- Trihexyphenidyl Hydrochloride Oral Solution, USP, 2mg/5mL, 473 mL bottles, Rx only, Distributed by: VersaPharm, Inc. - An Akorn Company- Lake Forest, IL 60045. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Oral Solution
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · stability unverified
See all →- HighFluticasone Propionate Nasal Spray Recalled Due to Manufacturing Quality Concerns
FDA (Drugs) · 2023-06-07
- ModerateAkorn Recalls Cromolyn Sodium Ophthalmic Solution Over Stability Studies
FDA (Drugs) · 2023-06-07
- ModerateFerrous Sulfate Iron Supplement Drops Recalled for Manufacturing Stability Issues
FDA (Drugs) · 2023-06-07
- HighNeomycin and Polymyxin B Eye Ointment Recalled for Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighClobetasol Propionate Ointment recalled due to manufacturing compliance failures
FDA (Drugs) · 2023-06-07
Similar recalls
- ModerateHi-Tech Pharmacal Recalls Subpotent HydrOXYzine Hydrochloride Oral Solution
FDA (Drugs) · 2013-06-26
- SevereAkorn Recalls Phenylephrine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- LowHi-Tech Pharmacal Recalls Acyclovir Oral Suspension for Stability Failures
FDA (Drugs) · 2014-01-01
- LowOxycodone Hydrochloride Oral Solution Recalled for Stability Failure
FDA (Drugs) · 2014-08-06
- ModerateAkorn Recalls Sulfamethoxazole and Trimethoprim Oral Suspension for Dissolution Failure
FDA (Drugs) · 2015-05-20
- SevereAkorn Recalls Hydroxyzine Hydrochloride Oral Solution Due to Impurities
FDA (Drugs) · 2015-06-17